This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Chikako Nishigori, MD, PhD; Shin-ichi Moriwaki, MD, PhD; Hiraku Takebe, PhD; Toshihiro Tanaka, MD, PhD; Sadao Imamura, MD, PhD

Arch Dermatol. 1994;130(2):191-197.

Abstract
Background and Design
The responsible gene for xeroderma pigmentosum group A was recently identified. This study was performed to detect the gene alteration of xeroderma pigmentosum group A complementing gene in 29 xeroderma pigmentosum group A patients in Japan and to analyze whether genetic alterations in the xeroderma pigmentosum group A complementing gene are related to the clinical features.

Results
Of 29 patients, 25 (86%) had a mutation at the splicing junction of intron 3 and exon 4 in the homozygous state that was detected by the polymerase chain reaction and the AlwN I-restriction fragment length polymorphism. Patients having a splicing mutation at intron 3 in the homozygous state develop severe skin manifestations from early infancy and severe progressive neurologic abnormalities, including sensorineural hearing impairment, brain atrophy, mental retardation, areflexia, and ataxia. Four patients were heterozygous for splicing mutation in intron 3. Among them, at least three patients showed milder skin symptoms and milder neurologic abnormalities than patients with the homozygous splicing mutation. Two patients (single-ovum twins) revealed a compound heterozygote of splicing mutation of intron 3 and a nonsense mutation of exon 6. One patient had the splicing mutation and another mutation at the last codon of exon 5, a type of mutation that has never been reported.

Conclusion
These data indicate that different genetic alterations in the xeroderma pigmentosum group A complementing gene may induce different clinical features.

(Arch Dermatol. 1994;130:191-197)

Author Affiliations
From the Department of Dermatology (Drs Nishigori, Moriwaki, Tanaka, and Imamura) and Experimental Radiology (Dr Takebe), Faculty of Medicine, Kyoto (Japan) University.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Christen-Zaech et al.
Arch Dermatol 2009;145:1285-1291.
ABSTRACT | FULL TEXT  

8-Oxoguanine Formation Induced by Chronic UVB Exposure Makes Ogg1 Knockout Mice Susceptible to Skin Carcinogenesis
Kunisada et al.
Cancer Res. 2005;65:6006-6010.
ABSTRACT | FULL TEXT  

Molecular Studies of Japanese Patients With Group A Xeroderma Pigmentosum Using Polymerase Chain Reaction and Restriction Fragment Length Polymorphism and Nonradioactive Single Strand Conformation Polymorphism Analyses
Sumitani et al.
J Child Neurol 1999;14:168-172.
ABSTRACT